Cureus · 2025
Preoperative Temporal Muscle Volume as an Independent Prognostic Marker in Glioblastoma.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sarkadi Attila, Egermann Hannes, Mueller Adolf, Lackermair Stephan
Аннотация
BACKGROUND AND OBJECTIVE: Sarcopenia has emerged as a relevant prognostic factor across solid tumors, but its impact in glioblastoma is not fully defined. Temporal muscle measurements on routine cranial imaging offer a pragmatic surrogate of systemic muscle mass in patients who rarely undergo body computed tomography (CT). This study aimed to evaluate whether preoperative bilateral temporal muscle volume is associated with overall survival in adults with glioblastoma, independently of established clinical and molecular prognostic factors.
METHODS: We conducted a retrospective, single-center cohort study including 83 adults with histologically confirmed glioblastoma who underwent tumor-directed neurosurgical procedures between January 2020 and July 2024 and had preoperative imaging suitable for temporal muscle assessment. Bilateral temporal muscle volume was obtained by summing right and left temporal muscle volumes and analyzed as a continuous variable and as a dichotomous variable based on the cohort median. Overall survival, defined from last tumor-directed surgery to death or last follow-up, was analyzed using Kaplan-Meier methods and Cox proportional hazards regression adjusted for age, sex, preoperative Karnofsky Performance Status, surgery type, postoperative treatment, isocitrate dehydrogenase mutation status, and O6-methylguanine-DNA methyltransferase promoter methylation status.
RESULTS: Patients in the low-volume group had shorter median overall survival than those in the high-volume group (312 vs 492 days, log-rank p = 0.003). Temporal muscle volume correlated positively with survival time (Spearman r = 0.37, p = 0.001), whereas age correlated negatively (r = -0.35, p = 0.002). In multivariable analysis, higher temporal muscle volume remained independently associated with reduced mortality risk (hazard ratio per standard-deviation increase 0.68, 95% confidence interval 0.52-0.89, p = 0.004).
CONCLUSION: Preoperative bilateral temporal muscle volume is an independent prognostic marker in glioblastoma and may help refine risk stratification and guide supportive care in routine neuro-oncologic practice.
METHODS: We conducted a retrospective, single-center cohort study including 83 adults with histologically confirmed glioblastoma who underwent tumor-directed neurosurgical procedures between January 2020 and July 2024 and had preoperative imaging suitable for temporal muscle assessment. Bilateral temporal muscle volume was obtained by summing right and left temporal muscle volumes and analyzed as a continuous variable and as a dichotomous variable based on the cohort median. Overall survival, defined from last tumor-directed surgery to death or last follow-up, was analyzed using Kaplan-Meier methods and Cox proportional hazards regression adjusted for age, sex, preoperative Karnofsky Performance Status, surgery type, postoperative treatment, isocitrate dehydrogenase mutation status, and O6-methylguanine-DNA methyltransferase promoter methylation status.
RESULTS: Patients in the low-volume group had shorter median overall survival than those in the high-volume group (312 vs 492 days, log-rank p = 0.003). Temporal muscle volume correlated positively with survival time (Spearman r = 0.37, p = 0.001), whereas age correlated negatively (r = -0.35, p = 0.002). In multivariable analysis, higher temporal muscle volume remained independently associated with reduced mortality risk (hazard ratio per standard-deviation increase 0.68, 95% confidence interval 0.52-0.89, p = 0.004).
CONCLUSION: Preoperative bilateral temporal muscle volume is an independent prognostic marker in glioblastoma and may help refine risk stratification and guide supportive care in routine neuro-oncologic practice.